Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
Uterine cervical cancer is one of the leading causes of cancer-related mortality in women worldwide. Each year, over half a million new cases are estimated, resulting in more than 300,000 deaths. While less-invasive, fertility-preserving surgical procedures can be offered to women in early stages, t...
Guardado en:
Autores principales: | Maximilian Fleischmann, Georgios Chatzikonstantinou, Emmanouil Fokas, Jörn Wichmann, Hans Christiansen, Klaus Strebhardt, Claus Rödel, Nikolaos Tselis, Franz Rödel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1a25d87ef9f46f1a1e8ad9cd3d0d1ba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
por: Manuel Behmueller, et al.
Publicado: (2021) -
Effects of c-FLIPL Knockdown in Cervical Uterine Carcinoma Cell Lines
por: Ili,Carmen G, et al.
Publicado: (2015) -
LASSO and Bioinformatics Analysis in the Identification of Key Genes for Prognostic Genes of Gynecologic Cancer
por: Shao-Hua Yu, et al.
Publicado: (2021) -
A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival
por: Mari K. Halle, et al.
Publicado: (2021) -
COMPARE THE LEVEL OF SQUAMOUS CELL CARCINOMA ANTIGEN IN SERUM AND LOCAL IMMUNITY OF THE REPRODUCTIVE TRACT IN WOMEN WITH INVASIVE FORM OF CERVICAL CANCER
por: I. L. Baturina, et al.
Publicado: (2014)